Xiaoli He

Title: Innovations of Xiaoli He in Anti-Tumor Research

Introduction

Xiaoli He is an accomplished inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of anti-tumor agents. His innovative work has led to the creation of a unique compound that shows promise in cancer treatment.

Latest Patents

Xiaoli He holds a patent for "15-oxospiramilactone derivatives, preparation method and uses thereof." This invention relates to a derivative of 15-oxospiramilacton, specifically focusing on compounds of Formula I or II, or their isomers, solvates, or pharmaceutically acceptable salts. The patent also covers a pharmaceutical composition that includes the compound as a pharmaceutically active ingredient, along with methods for its preparation and use in manufacturing anti-tumor agents. The derivative exhibits activity against multiple tumor cell lines, with its anti-tumor efficacy positively correlated to the inhibition of the Wnt signaling pathway. He has 1 patent to his name.

Career Highlights

Xiaoli He has worked at prestigious institutions such as the Chinese Academy of Sciences and the Shanghai Institutes of Biological Sciences. His research has focused on developing innovative solutions for cancer treatment, showcasing his dedication to advancing medical science.

Collaborations

Xiaoli has collaborated with notable colleagues, including Xiaojiang Hao and Chen Yan, who have contributed to his research endeavors. Their teamwork has played a crucial role in the success of his projects.

Conclusion

Xiaoli He is a prominent inventor whose work in anti-tumor research has the potential to impact cancer treatment significantly. His innovative compounds and dedication to pharmaceutical development highlight the importance of research in combating serious health challenges.